Population genetics of familial Mediterranean fever: A review

European Journal of Human Genetics

Volumn 15, Issue 9, 2007, Pages 911-916

  Yepiskoposyan, Levon ^a   Harutyunyan, Ashot ^a  

^a Institute of Man   (Armenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENE PRODUCT; MEDITERRANEAN FEVER PROTEIN; PROTEIN MEFV; UNCLASSIFIED DRUG;

CLINICAL FEATURE; CULTURAL ANTHROPOLOGY; ENVIRONMENTAL FACTOR; EPIGENETICS; FAMILIAL MEDITERRANEAN FEVER; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; INCIDENCE; INFECTION; MICROSATELLITE MARKER; MIGRATION; MORTALITY; MUTATIONAL ANALYSIS; POPULATION GENETICS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; Y CHROMOSOME;

CULTURAL CHARACTERISTICS; CYTOSKELETAL PROTEINS; EMIGRATION AND IMMIGRATION; ENVIRONMENT; FAMILIAL MEDITERRANEAN FEVER; GENETICS, POPULATION; HETEROZYGOTE; HUMANS; MUTATION; SELECTION (GENETICS);

EID: 34548186724     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201869     Document Type: Review

References (74)

1. Pras E, Langevitz P, Livneh A et al: Genotype phenotype correlation in familial Mediterranean fever (a preliminary report); in Sohar E, Gafni J, Pras M (eds).: Familial Mediterranean Fever. Tel Aviv: Freund Publishing House, 1997, pp 260-264.
2. Livneh A, Langevitz P, Shinar Y et al: MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999; 6: 1-6.
3. Tamir N, Langevitz P, Zemer D et al: Late-onset familial Mediterranean fever (FMF): A subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Hum Genet 1999; 87 30-35.
4. Cazeneuve C, Sarkisian T, Pecheux C et al: MEFV-gene analysis in Armenians patients with FMF: Diagnostic value, unfavorable renal prognosis of the M694V homozygous genotype, genetic and therapeutic implications. Am J Hum Genet 1999; 65: 88-97.
5. Shohat M, Magal N, Shohat T et al: Phenotype-genotype correlation in familial Mediterranean fever: Evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999; 7: 287-292.
6. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R: The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum 2001; 44: 1416-1419.
7. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A: The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003; 48: 1149-1155.
8. Notamicola C, Didelot M-N, Kone-Paut I, Seguret F, Demaille J, Touitou I: Reduced MEFV Messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum 2002; 46: 2785-2793.
9. The International FMF Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
10. Holmes A, Booth D, Hawkins P: Familial Mediterranean fever gene. N Engl Med 1998; 338: 992-993.
11. Aksentijevich I, Torosyan Y, Samuels J et al: Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 949-962.
12. Booth DR, Lachmann HJ, Gillmore JD, Booth SE, Hawkins PN: Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. Q J Med 2001; 94: 527-531.
13. Mansour I, Delague V, Cazeneuve C et al: Familial Mediterranean fever in Lebanon: Mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M6941 mutations. Eur J Hum Genet 2001; 9: 51-55.
14. Yilmaz E, Ozen S, Balci B et al: Mutation frequency of familial Mediterrarean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 553-555.
15. Aldea A, Calafell F, Arostegui JI et al: The West Side Story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination "hot-spot" at the MEFV locus. Hum Mutat 2004; 23: E399.
16. Al-Alami JR, Tayeh MK, Najib DA et. al: Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population. Saudi Med J 2003; 24: 1055-1059.
17. Atagunduz MP, Tuglular S, Kantarci G, Akoglu E, Direskeneli H: Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis. Nephron Clin Pract 2004; 96: 131-135.
18. Ayesh SK, Nassar SM, Al-Sharef WA, Abu-Libdeh BY, Darwish HM: Genetic screening of familial Mediterranean fever mutations in the Palestinian population. Saudi Med J 2005; 26: 732-737.
19. Sarkisian T, Ajrapetyan H, Shahsuvaryan G: Molecular study of FMT patients in Armenia. Curr Drug Targets Inflamm Allergy 2005; 4 113-116.
20. Turkish FMF Study Group: Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study. Medicine (Baltimore) 2005; 84: 1-11.
21. Belmahi L, Sefiani A, Fouveau C et al: Prevalence and distribution, of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. C R Biol 2006; 329 71-74.
22. Mattit H, Joma M, Al-Cheikh S et al: Familial Mediterranean fever in the Syrian population: Gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet 2006; 49: 481-486.
23. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
24. Babior BM, Matzner Y: The familial Mediterranean-fever gene - cloned at last. N Eng J Med 1997; 337: 1548-1549.
25. Centola M, Wood G, Frucht DM et al: The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in responsee to infammatory mediators. Blood 2000; 95: 3223-3231.
26. Shinawi M, Brik R, Berant M, Kasinetz L, Gershoni-Baruch R: Familial Mediterranean fever: High gene frequency and heterogeneous disease among an Israeli-Arab population. J Rheumatol 2000; 27: 1492-1495.
27. Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R: Familial Mediterranean fever: Prevalence, penetrance and genetic drift. Eur J Hum Genet 2001; 9: 634-637.
28. Dewalle M, Domingo C, Rozembaum M et al: Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998; 6: 95-97.
29. Cazeneuve C, Ajrapetyan H, Papin S et al: Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67: 1136-1143.
30. Ben-Chetrit E, Lerer I, Malamud E, Domingo C, Abeliovich D: The E148Q mutation in the MEFV gene: Is it a disease-causing mutation or a sequence variant? Hum Mutat 2000; 15: E385-e386.
31. Booth DR, Gilmore JD, Lachmann HJ et al: The genetic basis of autosomal dominant familial Mediterranean fever. Q J Med 2000; 93: 217-221.
32. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A: The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002; 10: 145-149.
33. Aldea A, Casademont J, Aróstegui JI et al: 1591 T MEFV mutation in a Spanish kindred: Is it a mild mutation, a benign polymorphism, or a variant influenced by another modifier? Hum Mutat 2002; 20: e148-e150.
34. Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S: The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2003; 22: 339-340.
35. Topaloglu R, Ozaltin F, Yilmaz E et al: E148Q is a disease-causing MEFV mutation: A phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis 2005; 64: 750-752.
36. Pras E, Livneh A, Balow Jr JE et al: Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998; 75: 216-219.
37. Booth DR, Gillmore JD, Booth SE, Pepys MB, Hawkins PN: Pyrin/Marenostrin mutations in familial Mediterranean fever. Q J Med 1998; 91: 603-606.
38. Touitou I, Ben-Chetrit E, Notarnicola C et al: Familial Mediterranean fever (FMF) clinical and genetic features in Druzes and Iraqi-Jews: A preliminary study. J Rheumatol 1998; 25: 916-919.
39. Yalçýnkaya F, Cakar N, Misirlioglu M et al: Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: Evidence for mutation-independent amyloidosis. Rheumatology 2000; 39: 67-72.
40. Livneh A, Aksentijevich I, Langevitz P et al: A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet 2001; 9 191-196.
41. Touitou I: The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473-483.
42. Touitou I, Picot M-C, Domingo C et al: The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001; 44: 163-169.
43. Cazeneuve C, Hovannesyan Z, Genevieve D et al: Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 2003; 48: 2324-2331.
44. Padeh S, Shinar Y, Pras E et al: Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever. J Rheumatol 2003; 30: 185-190.
45. Akar N, Misiroglu M, Yalçýnkaya F et al MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 190; 15: E118-e119.
46. Dode C, Pecheux C, Cazeneuve C et al: Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever. Am J Hum Genet 2000; 92: 241-246.
47. Kogan A, Shinar Y, Lidar M et al: Common MEFV mutations among Jewish ethnic groups in Israel: High frequency of carrier and phenotype III states and-absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001; 102: 272-276.
48. Hawkins PN, Gillmore JD, Booth SE et al: Pyrin E148Q is prevalent globally and may upregulate the inflammatory response non-specifically. Abstracts of the familial Mediterranean fever II international conference, 3-7 May, 2000, Antalya, Turkey. Clin Exp Rheumatol 2000; 18: A-4.
49. Bernot A, da Silva C, Petit J-L et al: Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 1998; 7: 1317-1325..
50. La Regina M, Nucera G, Diaco M et al: Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2003; 11 50-56.
51. Konstantopoulos K, Kanta A: Familial Mediterranean fever seems to be not uncommon in Greece. Eur J Hum Genet 2004; 12: 85-86.
52. Constantinou Deltas C, Mean R, Rossou E et al: Familial Mediterranean fever (FMF) is a frequent disease in the Greek-Cypriot population of Cyprus. Genet Test 2002; 6: 15-21.
53. Ozen S, Akarsu AN, Saatci U, Bakkaloglu A, Sarfarazi M: Linkage study of Turkish familial Mediterranean fever (IMF) to 16p13.3 and evidence for genetic heterogeneity. Am J Hum Genet 1996; 59 (Suppl.): A231.
54. Levy EN, Shen Y, Kupelian A et al: Linkage disequilibrium. mapping places the gene causing familial Mediterranean fever close to D16S246. Am J Hum Genet 1996; 58: 523-534.
55. Balow Jr JE, Shelton DA, Orsborn A et al: A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics 1997; 44: 280-291.
56. Chen X, Fischel-Ghodsian N, Cercek A et al: Assessment of pyrin gene mutations in Turks with familial Mediterranean fever (FMF). Hum Mutat 1998; 11: 456-460.
57. Aksentijevich I, Pras E, Gruberg L et al: Familial Mediterranean fever (FMF) in Moroccan Jews: Demonstration of a founder effect by extended haplotype analysis.Am J Hum Genet 1993; 53: 644-651.
58. Centola M, Aksentilevich I, Kastner DL: The hereditary periodic fever syndromes: Molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998; 7: 1581-1588.
59. Medlej-Hashim M, Rawashdeh M, Chouery E et al: Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients. Hum Mutat 2000; 15: E384.
60. Ben-Chetrit E, Urieli-Shoval S, Calko S, Abellovich D, Matzner Y: Molecular diagnosis of FMF: Lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol 2002; 20 (Suppl): S25-S29.
61. Mimouni A, Magal N, Stoffman N et al: Familial Mediterranean fever: Effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000; 105: E70.
62. Rogers D, Shohat M, Peterson GM et al: Familial Mediterranean fever in Armenians: Autosomal recessive inheritance with high gene frequency. Am J Hum Genet 1989; 34: 168-172.
63. Aivasian AA, Savgorodniaia AM, Abramian MK: Immunogenesis of Periodic disease. Klin Med (Mosk) 1977; 55: 41-97.
64. Eliakim. M, Levy M, Ehrenfeld M: Recurrent Polyserositis, Familial Mediterranean Fever, Periodic Disease. Amsterdam: Elsevier/ North-Holland Biomedical Press, 1981.
65. Khoury SA, Massad D: Consanguineous marriage in Jordan. Am J Med Genet 1992; 43: 769-775.
66. Al-Salem M, Rawashdeh N: Ponsanguinity in north Jordan: prevalence and pattern. J Biosoc Sci 1993; 25: 553-556.
67. Rawashdeh M, Majeed HA: Familial Mediterranean fever in Arab children: the high prevalence and gene frequency. Eur J Pediatr 1996; 515 540-544.
68. Majeed HA, Rawashdeh M, Qubain H: Recurrent episodic fever. A presenting feature of familial Mediterranean fever. J Med Liban 1998; 46 12-15.
69. Chae JJ, Komarow HD, Cheng J et al: Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003; 11: 591-604.
70. Brenner-Ullman A, Melzer-Ofir H, Daniels M, Shohat M: Possible protection against asthma in heterozygotes for familial Mediterranean fever. Am J Med Genet 1994; 53: 172-175.
71. Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G: Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet 2000; 8: 367-371.
72. Ross JJ: Goats, gerAs, and fever: are the pyrin mutations responsible for familial Mediterranean fever protective against Brucellosis? Med Hypotheses 2006; 68: 499-501.
73. Weale ME, Yepiskoposyan L, Jager RF et al: Armenian Y chromosome haplotypes reveal strong regional structure within a single ethno-national group. Hum Genet 2001; 109: 659-674.
74. Yepiskoposyan LM, Oganesyan NA, Khudoyan AT: Variation in Short Tandem Repeats of human Y chromosome. Genetika 2001; 37: 926-931.